Your account is not claimed yet. You can sign up with ORCID to claim your account.

Eric D Eisenmann

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Cancers

Pharmaceutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Basic & clinical pharmacology & toxicology

Ohio Northern University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Ohio Northern University

United States

BSC :: Psychology

Publications

Eric D Eisenmann, Alex Sparreboom
Unique Cabozantinib Dosing Considerations in People Living with HIV and Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yang Li, Yan Jin, Hanieh Taheri, Keith T Schmidt, Alice A Gibson, Stefan A J Buck, Eric D Eisenmann, Ron H J Mathijssen, William Douglas Figg, Sharyn D Baker, Alex Sparreboom, Shuiying Hu
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities. Pharmaceutics 14 (9) (2022)
Dominique A Garrison, Yan Jin, Zahra Talebi, Shuiying Hu, Alex Sparreboom, Sharyn D Baker, Eric D Eisenmann
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B. Molecules (Basel, Switzerland) 27 (20) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Dominique A Garrison, Zahra Talebi, Yan Jin, Josie A Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R Savona, Alice S Mims, Sharyn D Baker
Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics 14 (4) (2022)
Muhammad Erfan Uddin, Eric D Eisenmann, Yang Li, Kevin M Huang, Dominique A Garrison, Zahra Talebi, Alice A Gibson, Yan Jin, Mahesh Nepal, Ingrid M Bonilla, Qiang Fu, Xinxin Sun, Alec Millar, Mikhail Tarasov, Christopher E Jay, Xiaoming Cui, Heidi J Einolf, Ryan M Pelis, Sakima A Smith, Przemysław B Radwański, Douglas H Sweet, Martin F Fromm, Martin F Fromm, Cynthia A Carnes, Shuiying Hu, Alex Sparreboom
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. International journal of molecular sciences 23 (15) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Daelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, Jae Yoon Jeon, Eric D Eisenmann, Jack C Stromatt, Navjot Singh Pabla, James S Blachly, Sharyn D Baker, Bradley W Blaser
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors. Blood advances 6 (17) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Kevin M Huang, Megan Zavorka Thomas, Tarek Magdy, Eric D Eisenmann, Muhammad Erfan Uddin, Duncan F DiGiacomo, Alexander Pan, Markus Keiser, Marcus Otter, Sherry H Xia, Yang Li, Yan Jin, Qiang Fu, Alice A Gibson, Ingrid M Bonilla, Cynthia A Carnes, Kara N Corps, Vincenzo Coppola, Sakima A Smith, Daniel Addison, Anne T Nies, Ralf Bundschuh, Taosheng Chen, Maryam B Lustberg, Joanne Wang, Stefan Oswald, Moray J Campbell, Pearlly S Yan, Sharyn D Baker, Shuiying Hu, Paul W Burridge, Alex Sparreboom
Targeting OCT3 attenuates doxorubicin-induced cardiac injury. Proceedings of the National Academy of Sciences of the United States of America 118 (5) (2021)
Eric D Eisenmann, Zahra Talebi, Alex Sparreboom, Sharyn D Baker
Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions. Basic & clinical pharmacology & toxicology (2021)
Koen G A M Hussaarts, Leni van Doorn, Karel Eechoute, Jeffrey Damman, Qiang Fu, Nadia van Doorn, Eric D Eisenmann, Alice A Gibson, Esther Oomen-de Hoop, Peter de Bruijn, Sharyn D Baker, Stijn L W Koolen, Teun van Gelder, Roelof W F van Leeuwen, Ron H J Mathijssen, Alex Sparreboom, Sander Bins
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib. Pharmaceutics 12 (9) (2020)
Dominique A Garrison, Zahra Talebi, Eric D Eisenmann, Alex Sparreboom, Sharyn D Baker
Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. Pharmaceutics 12 (9) (2020)
Hiroto Inaba, John C Panetta, Stanley B Pounds, Yong-Dong Wang, Lie Li, Fariba Navid, Sara M Federico, Eric D Eisenmann, Aksana Vasilyeva, Sheila Shurtleff, Ching-Hon Pui, Tanja A Gruber, Raul C Ribeiro, Jeffrey E Rubnitz, Sharyn D Baker
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)

Eric D Eisenmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eric D Eisenmann